These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34871513)

  • 1. Effects of nicorandil on systemic inflammation and oxidative stress induced by percutaneous coronary intervention in patients with coronary heart disease.
    Zong Y; Li J; Xu X; Xu X
    J Int Med Res; 2021 Dec; 49(12):3000605211058873. PubMed ID: 34871513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of intracoronary nicorandil before stent deployment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xu X; Liu X; Yu L; Ma J; Yu S; Ni M
    Exp Ther Med; 2020 Jan; 19(1):137-146. PubMed ID: 31853283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention.
    Hu K; Wang X; Hu H; Xu Z; Zhang J; An G; Su G
    J Cell Mol Med; 2020 Apr; 24(8):4863-4870. PubMed ID: 32175662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
    Pang Z; Zhao W; Yao Z
    Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
    Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
    Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.
    Hirohata A; Yamamoto K; Hirose E; Kobayashi Y; Takafuji H; Sano F; Matsumoto K; Ohara M; Yoshioka R; Takinami H; Ohe T
    EuroIntervention; 2014 Jan; 9(9):1050-6. PubMed ID: 24457276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicorandil suppressed myocardial injury after percutaneous coronary intervention.
    Isono T; Kamihata H; Sutani Y; Motohiro M; Yamamoto S; Kyoui S; Iharada Y; Kurimoto K; Hara K; Takahashi H; Iwasaka T
    Int J Cardiol; 2008 Jan; 123(2):123-8. PubMed ID: 17346816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of nicorandil on ventricular arrhythmia in patients with acute ST-segment elevation myocardial infarction underwent emergent percutaneous coronary intervention treatment].
    Wang YP; Zhang Y; Sun YR; Sun ZG; Zuo ZK; Feng ZR; Chang FY; Xu YC; Chen BZ; Ye YY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Aug; 45(8):701-705. PubMed ID: 28851188
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of nicorandil infusion on ECG parameters in patients with unstable angina pectoris and percutaneous coronary intervention.
    Wang W; Zhang X; Chen K; Yin L; Gong M; Liu Y; Tse G; Wu L; Li G; Liu T
    Ann Noninvasive Electrocardiol; 2020 Jul; 25(4):e12736. PubMed ID: 31849155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The periprocedural myocardial damage prevention during elective percutaneous coronary intervention as a result of pharmacological preconditioning with an oral form of nicorandil in patients with stable coronary artery disease. Pilot study.
    Gostishchev RV; Soboleva GN; Samko AN; Rogoza AN; Minasyan AA
    Ter Arkh; 2018 Sep; 90(9):53-59. PubMed ID: 30701736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect on periprocedural myocardial infarction of intra-coronary nicorandil prior to percutaneous coronary intervention in stable and unstable angina.
    Hwang J; Lee HC; Kim BW; Yang MJ; Park JS; Park JH; Lee HW; Oh J; Choi JH; Cha KS; Hong TJ; Song S; Kim SP
    J Cardiol; 2013 Aug; 62(2):77-81. PubMed ID: 23731922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of oral nicorandil use in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    J Interv Cardiol; 2014 Oct; 27(5):472-81. PubMed ID: 25174952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
    An S; Huang H; Wang H; Jiang Y
    Medicine (Baltimore); 2021 Apr; 100(15):e25500. PubMed ID: 33847663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicorandil Reduces the Incidence of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography/Intervention - Systematic Review and Meta-Analysis of Randomized Controlled Trials Including GRADE Qualification.
    Pranata R; Vania R; Alkatiri AA; Firman D; Lukito AA
    Cardiovasc Revasc Med; 2020 Sep; 21(9):1121-1127. PubMed ID: 31959562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of nicorandil on myocardial injury following percutaneous coronary intervention in older patients with stable coronary artery disease: Secondary analysis of a randomized, controlled trial (RINC).
    Kawakita N; Ejiri K; Miyoshi T; Kohno K; Nakahama M; Doi M; Munemasa M; Murakami M; Nakamura K; Ito H;
    PLoS One; 2018; 13(4):e0194623. PubMed ID: 29659585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotective effects of single oral dose of nicorandil before selective percutaneous coronary intervention.
    Yang J; Zhang J; Cui W; Liu F; Xie R; Yang X; Gu G; Zheng H; Lu J; Yang X; Zhang G; Wang Q; Geng X
    Anatol J Cardiol; 2015 Feb; 15(2):125-31. PubMed ID: 25252296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI.
    Kostic J; Djordjevic-Dikic A; Dobric M; Milasinovic D; Nedeljkovic M; Stojkovic S; Stepanovic J; Tesic M; Trifunovic Z; Zamaklar-Tifunovic D; Radosavljevic-Radovanovic M; Ostojic M; Beleslin B
    Cardiovasc Ultrasound; 2015 May; 13():26. PubMed ID: 26012474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive Effects of Nicorandil Against Contrast-Induced Nephropathy in Patients With Moderate Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Zhang P; Li WY; Yang SC; Fu NK; Liu XG; Zhang X; Cong HL; Lin WH; Tian FS; Lu CZ; Zhang J
    Angiology; 2020 Feb; 71(2):183-188. PubMed ID: 30987432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of nicorandil on the prevention of contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention.
    Zhang X; Yang S; Zhang P; Fu N
    Coron Artery Dis; 2020 May; 31(3):284-288. PubMed ID: 31658134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.